Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH ‐ FOXF1 and TBX4 ‐ FGF10 Signaling Pathways
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64071 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Katarzyna Bzdęga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Poznan, Poland. Hauptthemen laut MEDLINE: T-Box Domain Proteins, Forkhead Transcription Factors, Hedgehog Proteins, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Science Centre in Poland.
Abstract (Originalsprache)
Lethal lung developmental disorders (LLDDs), histologically classified as alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), congenital alveolar dysplasia (CAD), acinar dysplasia (AcDys), and primary pulmonary hypoplasia (PH), are rare diseases associated with high neonatal mortality due to refractory respiratory failure. Although ACDMPV mostly results from single nucleotide variants (SNVs) or copy‐number variants (CNVs) involving FOXF1 , AcDys, CAD, and PH are often associated with abnormalities within TBX4 or FGF10 . These genes interact in the SHH‐FOXF1 and TBX4‐FGF10 signaling network and are known regulators of lung development. Recent studies conducted in TBX4‐ , FGF10‐ , or FOXF1‐ deficient LLDD lungs revealed decreased expression of TMEM100 at the transcriptomic and immunohistochemical levels. Here, we present four new patients with genetically and histopathologically confirmed LLDD, including ACDMPV ( n = 2), AcDys ( n = 1), and PH ( n = 1), in whom we detected a heterozygous variants involving FOXF1 ( n = 2) or TBX4 ( n = 2). Additional immunohistochemical (TMEM100) and qPCR analyses ( TMEM100 , TBX4 , FOXF1 ) performed in lung tissues of these newborns revealed a significant reduction in TMEM100 , TBX4 , and FOXF1 expression. Our results confirm previous findings indicating the possible involvement of TMEM100 in FOXF1‐TBX4‐FGF10 molecular signaling that, when disrupted, may lead to LLDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
- Neonatal and Intensive Care Department, Rzeszów Provincial Hospital No. 2, Rzeszów, Poland.
- Faculty of Medicine, University of Rzeszów, Rzeszów, Poland.
ORCID-Profile: Dariia Klepach, Justyna A Karolak
Förderung
- National Science Centre in Poland
Zitieren
APA
Bzdęga, K., Deutsch, G. H., Rydzanicz, M., Błaż, W., Rafińska-Ważny, E., Terpin, A. P., Klepach, D., Zakharova, V., Płoski, R., Szczapa, T., & Karolak, J. A. (2025). Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH ‐ FOXF1 and TBX4 ‐ FGF10 Signaling Pathways. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64071
Vancouver
Bzdęga K, Deutsch GH, Rydzanicz M, Błaż W, Rafińska-Ważny E, Terpin AP, et al. Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH ‐ FOXF1 and TBX4 ‐ FGF10 Signaling Pathways. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64071
BibTeX
@article{Bzdga2025,
author = {Bzdęga, Katarzyna and Deutsch, Gail H and Rydzanicz, Małgorzata and Błaż, Witold and Rafińska-Ważny, Elżbieta and Terpin, Anna P and Klepach, Dariia and Zakharova, Valentyna and Płoski, Rafał and Szczapa, Tomasz and Karolak, Justyna A},
title = {Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH ‐ FOXF1 and TBX4 ‐ FGF10 Signaling Pathways},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64071}
}
EUVIMED